- Home
- AIT vs RGC Comparison
AIT vs RGC Comparison
Compare AIT & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AIT | RGC |
|---|---|---|
| Founded | 1923 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.8B | 8.4B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | AIT | RGC |
|---|---|---|
| Price | $258.10 | $16.06 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $291.00 | N/A |
| AVG Volume (30 Days) | ★ 239.4K | 207.6K |
| Earning Date | 10-28-2025 | 10-24-2025 |
| Dividend Yield | ★ 0.71% | N/A |
| EPS Growth | ★ 6.01 | N/A |
| EPS | ★ 10.39 | N/A |
| Revenue | ★ $4,664,003,000.00 | N/A |
| Revenue This Year | $7.57 | N/A |
| Revenue Next Year | $5.30 | N/A |
| P/E Ratio | $24.82 | ★ N/A |
| Revenue Growth | ★ 4.03 | N/A |
| 52 Week Low | $199.96 | $0.09 |
| 52 Week High | $280.95 | $83.60 |
Technical Indicators
Market Signals| Indicator | AIT | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 54.98 | 61.51 |
| Support Level | $254.70 | $10.50 |
| Resistance Level | $262.92 | $18.15 |
| Average True Range (ATR) | 6.05 | 1.54 |
| MACD | 1.21 | 0.57 |
| Stochastic Oscillator | 79.26 | 73.17 |
Price Performance
Historical ComparisonAbout AIT Applied Industrial Technologies Inc.
Applied Industrial Technologies Inc is a distributor of industrial products to the maintenance, repair, and operations market and the original equipment manufacturing industry. Further, the company provides engineering and design services for industrial and fluid power applications. The products include bearings, power transmission components, fluid power components and systems, industrial rubber products, linear motion components, safety products, oilfield supplies, and other industrial and maintenance supplies. The company's reportable segments are; Service Center Based Distribution which derives key revenue, and Engineered Solutions. Geographically, the company derives its key revenue from the United States and the rest from Canada and other countries.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.